HPLC of Formula: C8H4Cl2N2, New research progress on 2213-63-0 in 2021. Redox catalysis has been broadly utilized in electrochemical synthesis due to its kinetic advantages over direct electrolysis. 2213-63-0, Name is 2,3-Dichloroquinoxaline, molecular formula is C8H4Cl2N2. In a Article，once mentioned of 2213-63-0
A new series of potential antibacterial agents having tricyclic 1,2,4-triazolo-[4,3-a]quinoxaline fused with one or more heterocyclic rings was synthesized via several routes. The tricyclic 1-amino-4-chloro-1,2,4-triazolo[4,3-a]quinoxaline (2) and tetracyclic 1,6-diamino-bis-1,2,4-triazolo[4,3-a:3,4-c]quinoxaline (3) were synthesized from 2,3-dichloroquinoxaline (1) with two or four equivalents of thiosemicarbazide, respectively. Compound 2 was allowed to react with different aldehydes, alkoxides, cyclic amines, phenyl isothiocyanate, and t-butyl isocyanate to afford the corresponding quinoxaline derivatives. Moreover, compound 2 reacted with hydrazine hydrate to give compound 4 which was cyclized by carbon disulfide in alcoholic potassium hydroxide to give the tetracyclic compound 5. Compound 2 was subjected to another cyclocondensation reaction using diethyl ethoxymethylene malonate (DEMM), dimethyl acetylenedicarboxylate (DMAD), and ethyl cyanoacetate to give the tetracyclic compounds 18, 20, and 21, respectively. All the synthesized compounds were evaluated in vitro for antibacterial activity; compounds 18 and 20 were found to display the greatest antibacterial activities. Structural identification was provided by elemental analyses, IR, and 1H-NMR spectroscopy.
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.HPLC of Formula: C8H4Cl2N2, you can also check out more blogs about2213-63-0
Reference：
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1241 | ChemSpider